Li-Chun Liu

ORCID: 0000-0001-7022-8316 · 3 papers in corpus
2021
AIM2 Inflammasome in Tumor Cells as a Biomarker for Predicting the Treatment Response to Antiangiogenic Therapy in Epithelial Ovarian Cancer Patients.
Journal of clinical medicine ·doi:10.3390/jcm10194529

Antiangiogenic therapy, such as bevacizumab (BEV), has improved progression-free survival (PFS) and overall survival (OS) in high-risk patients with epithelial ovarian cancer (EOC) according to several clinical trials. Clinically, no reliab…

other 2021
Vitamin D in gynecological diseases
Journal of the Chinese Medical Association : JCMA ·doi:10.1097/JCMA.0000000000000607

BACKGROUND: Most reproductive system studies suggest the protective effects of vitamin D, but vitamin D deficiency and insufficiency are growing global health issues. The present study investigates the association between vitamin D deficien…

other 2020
The Potential Role of Complement System in the Progression of Ovarian Clear Cell Carcinoma Inferred from the Gene Ontology-Based Immunofunctionome Analysis
International journal of molecular sciences ·doi:10.3390/ijms21082824

Ovarian clear cell carcinoma (OCCC) is the second most common epithelial ovarian carcinoma (EOC). It is refractory to chemotherapy with a worse prognosis after the preliminary optimal debulking operation, such that the treatment of OCCC rem…